Cheilbio Co., Ltd.

A052670

KR7052670007

Pharmaceuticals

End-of-day quote Korea S.E. Other stock markets 06:00:00 2023-07-19 pm EDT			5-day change	1st Jan Change
2,080 ^KRW	-9.96%		-.--%	-.--%

2023	Cheilbio Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI
2023	Cheilbio Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	CI

Tranche Update on Cheilbio Co., Ltd.'s Equity Buyback Plan announced on April 13, 2022.

October 12, 2022 at 01:25 am EDT

From October 1, 2022 to October 12, 2022, the company has repurchased 0 shares, representing 0% for KRW 0 million. With this, the company has completed the repurchase of 1,246,452 shares, representing 4.41% for KRW 2,999.36 million under the buyback announced on April 13, 2022.

Latest news about Cheilbio Co., Ltd.

Cheilbio Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 14	CI
Cheilbio Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15	CI
Cheilbio Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-11	CI
Tranche Update on Cheilbio Co., Ltd.'s Equity Buyback Plan announced on April 13, 2022.	22-10-12	CI
Tranche Update on Cheilbio Co., Ltd.'s Equity Buyback Plan announced on April 13, 2022.	22-10-12	CI
Tranche Update on Cheilbio Co., Ltd.'s Equity Buyback Plan announced on April 13, 2022.	22-10-12	CI
Cheilbio Co., Ltd.'s Equity Buyback announced on April 13, 2022, has expired with 1,246,452 shares, representing 4.41% for KRW 2,999.36 million.	22-10-11	CI
Cheilbio Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-16	CI
Cheilbio Co., Ltd. announces an Equity Buyback for KRW 3,000 million worth of its shares.	22-04-12	CI
Cheilbio Co., Ltd. authorizes a Buyback Plan.	22-04-12	CI
Cheilbio Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-15	CI
Tranche Update on Cheilbio Co., Ltd.'s Equity Buyback Plan announced on March 23, 2018.	18-09-27	CI
Tranche Update on Cheilbio Co., Ltd.'s Equity Buyback Plan announced on March 23, 2018.	18-09-27	CI
Cheilbio Co., Ltd.'s Equity Buyback announced on March 23, 2018 has expired with 495,436 shares for KRW 1,984.53 million.	18-09-26	CI
Tranche Update on Cheilbio Co., Ltd.'s Equity Buyback Plan announced on March 23, 2018.	18-06-26	CI
Cheilbio Co., Ltd. announces an Equity Buyback for KRW 2,000 million worth of its shares.	18-03-23	CI
Cheilbio Co., Ltd. authorizes a Buyback Plan.	18-03-22	CI
Tranche Update on Cheilbio Co., Ltd.'s Equity Buyback Plan announced on July 5, 2017.	18-01-04	CI
Cheil Bio Co., Ltd.’s Equity Buyback announced on July 5, 2017 has expired.	18-01-03	CI
Tranche Update on Cheilbio Co., Ltd.'s Equity Buyback Plan announced on July 5, 2017.	17-10-09	CI
Cheil Bio Co., Ltd.'s Equity Buyback announced on March 10, 2017, has expired.	17-09-07	CI
Cheil Bio Co., Ltd. announces an Equity Buyback for KRW 2,000 million worth of its shares.	17-07-04	CI
Cheil Bio Co., Ltd. authorizes a Buyback Plan.	17-07-04	CI
Tranche Update on Cheil Bio Co., Ltd.'s Equity Buyback Plan announced on March 10, 2017.	17-06-12	CI
Cheil Bio Co., Ltd. announces an Equity Buyback for KRW 2,500 million worth of its shares.	17-03-10	CI

Chart Cheilbio Co., Ltd.

Duration

Period

More charts

Company Profile

Cheilbio Co., Ltd. is a Korea-based company engaged in the manufacturing of veterinary drugs. The Company's offerings consist of antibiotics, antimicrobials, lactobacillus, enzyme preparations, parasiticides, antiseptics, organic trace minerals, vaccines, diagnostic kits including enzyme-linked immunosorbent assay (ELISA) test kits, virus test kits and deoxyribonucleic acid (DNA) kits, as well as feed additives. The Companyâs products are used for cattle, pigs, chickens, pets and other animals. It supplies its products mainly to the domestic market.

Sector

Pharmaceuticals

Calendar

2024-05-12 - Q1 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Veterinary Drugs

	1st Jan change	Capi.
CHEILBIO CO., LTD.	-.--%	40.84M
ZOETIS INC.	-18.42%	72.97B
ELANCO ANIMAL HEALTH INCORPORATED	-9.33%	6.69B
BLUESTAR ADISSEO COMPANY	+21.38%	3.6B
VIMIAN GROUP AB	+2.36%	1.44B
JINYU BIO-TECHNOLOGY CO., LTD.	-16.99%	1.34B
VETOQUINOL SA	-7.52%	1.25B
CHINA ANIMAL HUSBANDRY INDUSTRY CO., LTD.	-26.05%	1.24B
WUHAN KEQIAN BIOLOGY CO.,LTD	-12.71%	1.15B
TIANJIN RINGPU BIO-TECHNOLOGY CO.,LTD.	-4.03%	1.01B